Some revered global brands have become unstuck in their internationalisation by ceding control of a brand without any quality assurance. Panellists at HBI 2021 discussed how to manage that process more effectively.
Increasing demand and rising costs are putting pressure on LatAm’s healthcare system. A regional session at HBI 2021 heard that out-of-pocket payments are on the increase, especially in Mexico.
Is healthcare in the Middle East and North Africa (MENA) the next big investment opportunity? According to a panel at HBI 2021 on the MENA region the answer is an emphatic yes, and the region is 'open for business - though not a market for the faint of heart.
It will take another decade for many healthcare providers to adequately structure their data in order to use AI to make a wide-ranging impact on patient outcomes. Most of the solutions in use today are still single-case, ranging from measuring body composition, detecting lung nodules and predicting the risk of a specific disease.
Demand for and interest in dental services from patients and investors continues to rise, with increased respect for dental platforms and a heightened awareness of aesthetic procedures.
Axa group in partnership with Microsoft has launched its digital healthcare platform in Italy and Germany this year, and has plans to launch in Spain, Belgium, and the UK in the next two weeks. An expert panel at HBI 2021 made up of Bupa, Cigna and Axa discusses how the Insurer market has changed and the future of digital platforms.
Infertility is up, maternity in many regions is down - and the global fertility market is continuing on an upwards trajectory largely untouched by Covid. It remains a hot ticket when it comes to M&A - though issues with regulation and staffing are causing some headaches.
Analysts and strategists in the diagnostics sector have been racking their heads over what business will look like in a post-Covid world. There is a lot of uncertainty over how much of the current Covid testing volume will remain, and how much growth will be seen in B2C demand for other disease testing.
Operators differ in their visions and ambitions for how digital tools can be used to transform the primary care and diagnostic sectors, from being purely a ‘marketing tool’ that can improve convenience and ease of access for patients, all the way to round-the-clock patient-tracking and data-gathering to be used in combination with genome sequencing and AI to predict and prevent illness and death.
Providers in emerging markets must better explore new business models - like subscription-based wellbeing and capitated primary care - if they want to fill the gap left by the public sector, panellists agreed at HBI 2021.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
